Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 05/31/21
Due: 05/31/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors | NCT01562626 | Anaeropharma Science, Inc. | user2@example.com | None | 2012-09-30 | 2021-05-31 | 2022-05-31 | - | - | 2025-07-14 |